LMAT - Lemaitre Vascular Inc
IEX Last Trade
90.305
1.685 1.866%
Share volume: 113,576
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$88.62
1.69
1.90%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-05 | 2022-11-08 | 2023-03-01 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-02-29 | |
| Assets | |||||||||
| Total Assets | 292.453 M | 299.425 M | 302.048 M | 310.476 M | 314.866 M | 326.467 M | 334.012 M | 346.778 M | |
| Current Assets | 141.411 M | 148.486 M | 153.142 M | 161.733 M | 164.768 M | 174.490 M | 182.184 M | 194.598 M | |
| Inventories | 41.348 M | 41.760 M | 42.434 M | 45.279 M | 48.868 M | 49.100 M | 51.264 M | 58.080 M | |
| Other Current Assets | 7.795 M | 8.675 M | 10.119 M | 11.723 M | 9.530 M | 8.807 M | 10.020 M | 6.380 M | |
| Short Term Investments | 7.795 M | 8.675 M | 10.119 M | 11.723 M | 9.530 M | 8.807 M | 10.020 M | 6.380 M | |
| Total Receivables | 21.386 M | 21.542 M | 20.094 M | 22.040 M | 25.365 M | 26.406 M | 23.882 M | 25.064 M | |
| Current Cash | 70.882 M | 75.683 M | 79.739 M | 82.691 M | 81.005 M | 90.177 M | 97.018 M | 105.074 M | |
| Total Non-current Assets | 151.042 M | 150.939 M | 148.906 M | 148.743 M | 150.098 M | 151.977 M | 151.828 M | 152.180 M | |
| Property Plant Equipment | 16.683 M | 15.753 M | 15.351 M | 17.901 M | 19.242 M | 21.217 M | 21.357 M | 21.754 M | |
| Other Assets | 556.000 K | 984.000 K | 973.000 K | 991.000 K | 2.074 M | 2.931 M | 3.152 M | 3.740 M | |
| Intangible Assets | 51.194 M | 49.598 M | 48.063 M | 46.527 M | 45.508 M | 43.999 M | 43.199 M | 41.711 M | |
| Goodwill | 65.945 M | 65.945 M | 65.945 M | 65.945 M | 65.945 M | 65.945 M | 65.945 M | 65.945 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 292.453 M | 299.425 M | 302.048 M | 310.476 M | 314.866 M | 326.467 M | 334.012 M | 346.778 M | |
| Total liabilities | 34.666 M | 41.392 M | 40.801 M | 42.275 M | 40.701 M | 42.640 M | 45.375 M | 48.878 M | |
| Total current liabilities | 18.267 M | 23.405 M | 23.439 M | 25.329 M | 23.904 M | 25.855 M | 29.029 M | 29.879 M | |
| Accounts Payable | 2.194 M | 2.844 M | 2.848 M | 2.903 M | 3.371 M | 3.519 M | 4.371 M | 3.734 M | |
| Other liabilities | 2.626 M | 2.503 M | 2.405 M | 2.167 M | 2.278 M | 2.264 M | 2.145 M | 2.268 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.626 M | 2.503 M | 2.405 M | 2.167 M | 2.278 M | 2.264 M | 2.145 M | 2.268 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 257.787 M | 258.033 M | 261.247 M | 268.201 M | 274.165 M | 283.827 M | 288.637 M | 297.900 M | |
| Common stock | 21.935 M | 21.958 M | 21.984 M | 22.023 M | 22.111 M | 22.213 M | 22.263 M | 22.281 M | |
| Retained earnings | 91.420 M | 92.190 M | 94.896 M | 97.773 M | 100.714 M | 105.696 M | 110.081 M | 115.430 M |